Dr. Adrian Harel

Prof. Schachner will collaborate with recently appointed CEO, Dr. Adrian Harel, in the ongoing Phase II Clinical trial on Hypotension in patients undergoing Cardio Artery Bypass Graft (CABG) patients and in designing future clinical trials.
...
Dr. Adrian Harel joined Meditor in January 2008.He combines a broad scientific education with extensive industry experience.He holds a Ph.D. in Neurobiology, from the Weizmann Institute of Science, and was a postdoctoral at Washington University.Dr. Harel has many years of experience in the pharmaceutical and biotech industry.Dr. Harel has extensive Drug research & development know-how and GMP production and manufacturing knowledge.
...
For all inquiries please contact Mr. Rafi Barkan, Chairman at +972 8 930 3307 or Dr. Adrian Harel, CEO at +972 8 930 3305.
...
CONTACT: Mr. Rafi Barkan, Chairman, +972 8 930 3307; or Dr. Adrian Harel,

appointed CEO, Dr. Adrian Harel, in the ongoing Phase II Clinical trial on Hypotension in patients undergoing Cardio Artery Bypass Graft (CABG) patients and in designing future clinical trials.

Dr. Adrian Harel joined Meditor in January 2008.He combines a broad scientific education with extensive industry experience.He holds a Ph.D. in Neurobiology, from the Weizmann Institute of Science, and was a postdoctoral at Washington University.Dr. Harel has many years of experience in the pharmaceutical and biotech industry.Dr. Harel has extensive Drug research & development know-how and GMP production and manufacturing knowledge.
...
930 3307 or Dr. Adrian Harel, CEO at +972 8 930 3305.

Dr. Adrian Harel, CEO of Meditor was quoted as saying: "We are planning to present these exciting results in an International Conference for Migraine in Europe.
...
For all inquiries please contact Mr. Rafi Barkan, Chairman at +972 8 930 3307 or Dr. Adrian Harel, CEO at +972 8 930 3305.
...
CONTACT: Mr. Rafi Barkan, Chairman, +972 8 930 3307, or Dr. Adrian Harel,

Dr. Adrian Harel, CEO of Meditor was quoted as saying: "We are planning
...
930 3307 or Dr. Adrian Harel, CEO at +972 8 930 3305.

Dr. Adrian Harel, CEO of Meditor was quoted as saying: "We are planning to present these exciting results in an International Conference for Migraine in Europe.
...
For all inquiries please contact Mr. Rafi Barkan, Chairman at +972 8 930 3307 or Dr. Adrian Harel, CEO at +972 8 930 3305.

Heal-Or, a Ramat Gan startup, has developed a topical therapy that helps the body use its own proteins to speed up the wound healing process and prevent deterioration, says Adrian Harel, CEO.

Dr. Adrian Harel- (CEO)

Dr. Adrian Harel joined Meditor in 2008. He combines a broad scientific education with extensive industry experience. He holds a Ph.D. in Neurobilogy, from the Weizmann Institute of Science, and was a postdoctoral at Washington University Dr. Harel many years of experience in the pharmaceutical and biotech industry (Interpharm, Proneuron, JBC, Heal-Or, Sepal Pharma and Molecular Cytomics). Dr. Harel has extensive Drug research & develpment know-how and GMP production and manufacturing knowledge.

Dr. Adrian Harel, CEO of Meditor was quoted as saying: "We are planning to present these exciting results in an International Conference for Migraine in Europe.
...
For more information on the company and its drug development activities, please visit www.meditorpharma.com For all inquiries please contact Mr. Rafi Barkan, Chairman at +972 8 930 3307 or Dr. Adrian Harel, CEO at +972 8 930 3305.
...
Prof. Schachner will collaborate with recently appointed CEO, Dr. Adrian Harel, in the ongoing Phase II Clinical trial on Hypotension in patients undergoing Cardio Artery Bypass Graft (CABG) patients and in designing future clinical trials.
...
Dr. Adrian Harel joined Meditor in January 2008. He combines a broad scientific education with extensive industry experience. He holds a Ph.D. in Neurobiology, from the Weizmann Institute of Science, and was a postdoctoral at Washington University. Dr. Harel has many years of experience in the pharmaceutical and biotech industry. Dr. Harel has extensive Drug research & development know-how and GMP production and manufacturing knowledge.
...
For all inquiries please contact Mr. Rafi Barkan, Chairman at +972 8 930 3307 or Dr. Adrian Harel, CEO at +972 8 930 3305.